Rejuvenation Technologies Inc. YC Application

Summer 2018Active

Rejuvenation Technologies Inc. went through Y Combinator in the Summer 2018 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2018
Industry: HealthcareTherapeutics
Team size: 2
Status: Active
Launched: 2018

Founders

Glenn MarkovFounder
John RamunasFounder

What Rejuvenation Technologies Inc. does

Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.

Rejuvenation Technologies Inc.'s YC application, reconstructed

Y Combinator application

Rejuvenation Technologies Inc., Summer 2018 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rejuvenation Technologies Inc.

Describe what your company does in 50 characters or less.

mRNA therapeutics to extend healthspan

What is your company going to make? Please describe your product and what it does or will do.

We develop an mRNA drug platform that extends healthspan by reversing telomere shortening. Our therapy extends mouse lifespan by the human equivalent of 10 years with a single dose, showing efficacy in multiple organ systems, including the immune system. We are entering clinical trials to validate this approach in humans, addressing the root cause of aging linked to short telomeres.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC as well.

Explain your decision regarding location.

San Francisco offers the right ecosystem of biotech expertise, funding, and clinical trial access. Being where the science and capital meet is necessary for our clinical-stage gene therapy startup.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Rejuvenation Technologies Inc. YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Rejuvenation Technologies Inc.'s public data (launch notes, founder backgrounds, product description). It shows how a company like Rejuvenation Technologies Inc. would present itself to YC, not the text they submitted.

What YC batch was Rejuvenation Technologies Inc. in?

Rejuvenation Technologies Inc. was part of the Y Combinator Summer 2018 batch.

Who founded Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. was founded by Glenn Markov, John Ramunas.

What does Rejuvenation Technologies Inc. do?

mRNA therapeutics to extend healthspan entering clinical trials

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Rejuvenation Technologies Inc.'s application, and every other YC batch, is in YC Insights.